EC359 Enhances Trametinib Efficacy in Ras/Raf-Driven Ovarian Cancer by Suppressing LIFR Signaling is a research paper published in Biomolecules (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
MCC Pilot grant
Grant: NIH R01 CA267893
MCC Pilot grant
Grant: NIH R01 CA266970-01A1
MCC Pilot grant
Grant: VA I01 BX006280-01
MCC Pilot grant
Grant: NCI F99 CA284284-01
MCC Pilot grant
Grant: NIH NCI R50 CA265339
Cancer Center at UT Health San Antonio
Grant: NIH-NCI P30 CA054174
NIH Shared Instrumentation
Grant: 1S10 OD030311-01
the CPRIT Core Facility Award
Grant: RP220662
NCI NIH HHS
Grant: R01 CA266970
NIH HHS
Grant: R01 CA267893
NCI NIH HHS
Grant: R50 CA265339
NCI NIH HHS
Grant: F99 CA284284
BLRD VA
Grant: I01 BX006280
UT Health Mays Cancer center
Grant: MCC Pilot grant
NCI NIH HHS
Grant: P30 CA054174
NIH HHS
Grant: S10 OD030311
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
MeSH Terms
Keywords